Study found that 69% of hospitalized COPD patients misused inhalers, with 66% making critical errors, and 14% having insufficient Peak Inspiratory Flow (PIF), even after training.
Intellia plays down concerns about accidental germline transmission in CRISPR trial
Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and
August 21, 2023